ATXN2 gene therapy (Maze therapeutics)

N/A

Report date: 2025/01/26 16:20:42

Base Information

Drug NameATXN2 gene therapy (Maze therapeutics)
Drug Alias NamemicroRNA gene therapy (Maze Therapeutics)
ClassificationBiologics
Mechanisms of ActionAtaxin-2 expression inhibitors
TargetsAtaxin-2
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaze Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Biosciences IncMaze Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A